NCT06070285View on ClinicalTrials.gov

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Recurrent Ovarian Cancer
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT06070285 - Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter